antineoplastisch middel
Heterocyclic compound
Protein-tyrosine kinase inhibitor
|
|
|
Ripretinib (substance)
Ripretinib
Id
876860008
Status
Primitive
Has disposition
proteïnetyrosinekinaseremmer